Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity

Anbarasi Kothandapani1, Kathirvel Gopalakrishnan, Bhaskar Kahali

  • 1Department of Biochemistry and Cancer Biology, University of Toledo-Health Science Campus, Toledo, OH 43614, USA.

Insights

The SWI/SNF chromatin remodeling complex, involving Brg1 and Brm, enhances cancer cell sensitivity to cisplatin by aiding DNA repair. Its depletion impairs the repair of cisplatin DNA adducts and double-strand breaks.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Chromatin Dynamics

Background:

  • The SWI/SNF chromatin remodeling complex is crucial for various cellular processes, including DNA repair.
  • Cisplatin is a widely used chemotherapy agent that induces DNA damage.

Purpose of the Study:

  • To investigate the role of SWI/SNF subunits Brg1 and Brm in the cellular response to cisplatin in lung and head/neck cancer cells.
  • To elucidate the mechanism by which SWI/SNF influences cisplatin-induced DNA damage repair.

Main Methods:

  • Stable knockdown of Brg1 and Brm in cancer cell lines.
  • Assessment of cellular sensitivity to cisplatin.
  • Analysis of DNA adduct repair kinetics and DNA double-strand break repair.
  • Evaluation of chromatin relaxation, checkpoint activation, and apoptosis.
  • Investigation of DNA damage recognition factor recruitment (XPC and ERCC1).

Main Results:

  • Knockdown of Brg1 and Brm increased cisplatin sensitivity.
  • Downregulation of Brg1 and Brm impaired the repair of cisplatin DNA adducts (intrastrand and interstrand crosslinks) and ICL-induced double-strand breaks.
  • Brg1 and Brm deficiency led to altered checkpoint activation, enhanced apoptosis, and impaired chromatin relaxation.
  • While XPC recruitment was unaffected, ERCC1 recruitment was impaired in Brg1 and Brm depleted cells.

Conclusions:

  • The SWI/SNF chromatin remodeling complex, through Brg1 and Brm, plays a significant role in modulating cisplatin cytotoxicity.
  • SWI/SNF facilitates efficient repair of cisplatin-induced DNA lesions, impacting therapeutic outcomes.
  • Targeting SWI/SNF may represent a strategy to enhance the efficacy of cisplatin chemotherapy.

Related Concept Videos

Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Nucleosome Remodeling02:54

Nucleosome Remodeling

Nucleosomes are the basic units of chromatin compaction. Each nucleosome consists of the DNA bound tightly around a histone core, which makes the DNA inaccessible to DNA binding proteins such as DNA polymerase and RNA polymerase. Hence, the fundamental problem is to ensure access to DNA when appropriate, despite the compact and protective chromatin structure.
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...